22.05.2024 - Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that three submitted .
As key decision makers contemplate the best pathway en route to these targets, they are paying attention to methane, documented as 80 times more harmful to the environment than CO2 and making up 40 percent of the state’s total greenhouse gas footprint. But with all its aspirations, New York is missing opportunities to capture and use one of the world’s top methane sources organic waste charges Energy Vision.